Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 19, 2023Thrombosis and Haemostasis

Recurrent Thrombosis and Bleeding in Patients with Cancer-Associated Venous Thromboembolism Receiving Anticoagulation: Are These Modifiable Risk Factors for Mortality?

View Full Paper
Ask AI
Bookmark
Share

Key result

The provided text contains only the journal's editorial board information and does not include the abstract or text of the article.

Population

Patients with cancer-associated venous thromboembolism (VTE)

Design

Editorial

Authors

KXKe XuNCNoel Chan

Discussion

Loading...

Member takes

Overview

Recurrent VTE fatality exceeds major bleeding in cancer-associated thrombosis; leaves open whether indefinite anticoagulation should be routinely extended.

Structured PICO

P
Population
Patients with cancer-associated venous thromboembolism (VTE)
E
Exposure
Anticoagulation

Recurrent VTE has a higher case fatality rate than major bleeding in patients with cancer-associated VTE, supporting guidelines for indefinite anticoagulation.

Cite This Study

Xu et al. (2023) studied Cancer-Associated Venous Thromboembolism. Anticoagulation was evaluated. The provided text contains only the journal's editorial board information and does not include the abstract or text of the article.

synapsesocial.com/papers/6a20e99434bef10fdaeb226fhttps://doi.org/10.1055/a-2015-8597
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epidemiology of cancer-associated venous thrombosis2013 · 1,219 citations
  2. 2Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism2013 · 129 citations
  3. 3Treatment and Bleeding Complications of Cancer-Associated Venous Thromboembolism: A Korean Population-Based Study2022 · 14 citations
  4. 4Racial and Ethnic Disparities in Cancer-Associated Thrombosis2021 · 15 citations
  5. 5Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease2010 · 233 citations